Effect of an intensive lifestyle intervention on the structural and functional substrate for atrial fibrillation in people with metabolic syndrome

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology..

AIMS: To evaluate the effect of an intensive lifestyle intervention (ILI) on the structural and functional cardiac substrate of atrial fibrillation (AF) in overweight or obese people with metabolic syndrome (Mets).

METHODS AND RESULTS: Participants of the PREvención con DIeta MEDiterranea-Plus trial (n = 6874) were randomized 1:1 to an ILI programme based on an energy-reduced Mediterranean diet, increased physical activity, and cognitive-behavioural weight management or to a control intervention of low-intensity dietary advice. A core echocardiography lab evaluated left atrial (LA) strain, function, and volumes in 534 participants at baseline, 3-year, and 5-year follow-ups. Mixed models were used to evaluate the effect of the ILI on LA structure and function. In the subsample, the baseline mean age was 65 years [standard deviation (SD) 5 years], and 40% of the participants were women. The mean weight change after 5 years was -3.9 kg (SD 5.3 kg) in the ILI group and -0.3 kg (SD 5.1 kg) in the control group. Over the 5-year period, both groups experienced a worsening of LA structure and function, with increases in LA volumes and stiffness index and decreases in LA longitudinal strain, LA function index, and LA emptying fraction over time. Changes in the ILI and control groups were not significantly different for any of the primary outcomes {LA emptying fraction: -0.95% [95% confidence interval (CI) -0.93, -0.98] in the control group, -0.97% [95% CI -0.94, -1.00] in the ILI group, Pbetween groups = 0.80; LA longitudinal strain: 0.82% [95% CI 0.79, 0.85] in the control group, 0.85% [95% CI 0.82, 0.89] in the ILI group, Pbetween groups = 0.24} or any of the secondary outcomes.

CONCLUSION: In overweight or obese people with Mets, an ILI had no impact on the underlying structural and functional LA substrate measurements associated with AF risk.

Errataetall:

UpdateOf: medRxiv. 2023 Sep 01;:. - PMID 37577657

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:31

Enthalten in:

European journal of preventive cardiology - 31(2024), 5 vom: 27. März, Seite 629-639

Sprache:

Englisch

Beteiligte Personen:

Rossello, Xavier [VerfasserIn]
Ramallal, Raúl [VerfasserIn]
Romaguera, Dora [VerfasserIn]
Alonso-Gómez, Ángel M [VerfasserIn]
Alonso, Alvaro [VerfasserIn]
Tojal-Sierra, Lucas [VerfasserIn]
Fernández-Palomeque, Carlos [VerfasserIn]
Martínez-González, Miguel Ángel [VerfasserIn]
Garrido-Uriarte, María [VerfasserIn]
López, Luis [VerfasserIn]
Díaz, Agnes [VerfasserIn]
Zaldua-Irastorza, Olatz [VerfasserIn]
Shah, Amit J [VerfasserIn]
Salas-Salvadó, Jordi [VerfasserIn]
Fitó, Montserrat [VerfasserIn]
Toledo, Estefania [VerfasserIn]

Links:

Volltext

Themen:

Atrial fibrillation
Intensive lifestyle intervention
Journal Article
Mediterranean diet
Metabolic syndrome
Obesity
Randomized Controlled Trial

Anmerkungen:

Date Completed 29.03.2024

Date Revised 30.03.2024

published: Print

UpdateOf: medRxiv. 2023 Sep 01;:. - PMID 37577657

Citation Status MEDLINE

doi:

10.1093/eurjpc/zwad380

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365927589